YGL235W Antibody

What is yeast surface display (YSD) and why is it valuable for antibody research?

Yeast surface display is a powerful technology that enables the presentation of recombinant antibodies on the exterior of yeast cells. The system typically utilizes the a-agglutinin system, where antibody fragments are genetically fused to Aga2p, which forms disulfide linkages with cell wall-anchored Aga1p .

This technology provides several key advantages:

• Eukaryotic expression system with proper protein folding machinery

• Post-translational modifications similar to mammalian cells

• Compatibility with fluorescence-activated cell sorting (FACS)

• Quantitative analysis at the monoclonal level

• Preserved antibody conformations, especially in Fab format

YSD has proven particularly valuable for antibody discovery and engineering, allowing researchers to conduct high-throughput screening and affinity maturation of antibodies with unprecedented efficiency .

Which antibody formats can be effectively displayed on yeast cell surfaces?

Several antibody formats can be displayed on yeast cells, each with distinct advantages:

Research indicates that Fab format is often more reliable than scFv for YSD. In one study, scFv display levels varied from 31-46%, while the same antibody clones in Fab format showed more consistent display levels (41-43%) . For some antibodies like Infliximab, only the Fab format could be successfully displayed on yeast cell surfaces .

How are antibody chains co-expressed in yeast display systems?

Efficient antibody display requires proper co-expression of heavy and light chains. Several approaches have been developed:

• Divergent promoter systems: A divergent GAL1-GAL10 promoter can be exploited by cloning Fab heavy chain and light chain downstream of GAL10 and GAL1, respectively. In the presence of galactose, expression of both chains is induced simultaneously .

• ER signal sequences: Yeast endoplasmic reticulum (ER) signal sequences are included at N-termini of both chains for translocation and secretory expression, enhancing proper folding and assembly .

• Dual expression vectors: These link heavy and light chain genes, reducing plasmid preparation time and stock requirements by half .

• Golden Gate Cloning: This technology uses type IIs restriction enzymes to efficiently generate plasmid clones, reducing the time required to create Ig plasmid libraries .

How are displayed antibodies detected and analyzed on yeast surfaces?

Several complementary methods are used to detect and analyze antibodies displayed on yeast:

• Epitope tag detection: FLAG tags (on heavy chains) and HA tags (on light chains) are commonly used, detected with fluorescently labeled anti-tag antibodies .

• Antigen binding assessment: Fluorescently labeled antigens at varying concentrations are used to evaluate binding function. For example, biotinylated antigens followed by fluorescent streptavidin detection allows quantification of binding .

• Flow cytometry analysis: This enables simultaneous measurement of antibody display level and antigen binding. According to research, "the population profile, defined by the fluorescence intensity during flow cytometry, directly reflected the affinity of a clone" .

• Sorting and enrichment: FACS enables collection of yeast cells displaying antibodies with desired properties for further analysis or additional rounds of selection .

What cultivation and induction conditions are optimal for antibody display in yeast?

Based on experimental protocols described in the literature:

• Growth media: Yeast transformants are typically selected on synthetic dropout (SD) media lacking specific amino acids to maintain plasmid selection .

• Induction conditions:

  • Cultivation in SD-CAA (glucose) media for growth

  • Induction in SG-CAA (galactose) media to activate GAL promoters

  • Typical induction times of 18-24 hours at 20-30°C

• Cell density: Approximately 1-5×10⁷ cells/ml is optimal for induction, with higher densities potentially reducing display efficiency .

• Post-induction handling: Cold temperature (4°C) and addition of BSA (0.2-1 mg/ml) during labeling steps help maintain antibody stability and reduce non-specific binding .

How can I optimize the efficiency of antibody display on yeast cell surfaces?

Several complementary approaches have been characterized for optimizing antibody display efficiency:

• Co-expression of molecular chaperones: "Co-expression of a Hsp70 family molecular chaperone Kar2p and/or protein-disulfide isomerase (Pdi1p) significantly improved efficiency of functional display" . These chaperones facilitate proper protein folding and disulfide bond formation within the ER.

• ER retention strategies: "Fusing ER retention sequences (ERSs) with light chain also enhanced Fab display quality at the expense of display quantity, and the degree of improvements was correlated with the strength of ERSs" . This approach increases the time antibody chains spend in the ER, enhancing assembly.

• Signal peptide optimization: Selection of appropriate ER signal peptides for both heavy and light chains can significantly impact translocation efficiency and subsequent display .

• Vector design optimization: Divergent promoters, optimal codon usage, and appropriate fusion sites can all enhance display efficiency .

These approaches represent important tradeoffs between quality and quantity of displayed antibodies that must be considered for individual antibody clones.

What molecular mechanisms govern proper antibody folding and assembly in yeast cells?

The search results highlight several critical mechanisms affecting antibody folding and assembly:

• ER chaperone activity: Kar2p (BiP) "binds to unfolded polypeptide chains and mediates protein folding within the ER. Only correctly folded proteins can be released from Kar2p, while abnormally folded or improperly assembled proteins are retained by Kar2p for later degradation" .

• Disulfide bond formation: "ER-associated protein disulfide isomerase (Pdi1p) catalyzed the disulfide bonds formation in eukaryotic cells" . This is crucial for the intermolecular disulfide connecting C-termini of CH1 and CL domains in Fab fragments.

• ER retention mechanisms: Prolonging the retention time of antibody chains in the ER through fusion with ERSs increases the probability of proper assembly, though it may decrease the total amount displayed .

• Quality control systems: The yeast ER contains quality control systems that ensure only properly folded proteins proceed through the secretory pathway. Improperly folded proteins are targeted for ER-associated degradation (ERAD) .

Understanding these mechanisms allows researchers to develop strategies to enhance the functional display of antibodies on yeast surfaces.

How can I integrate next-generation sequencing (NGS) with yeast display for antibody discovery?

The integration of NGS with yeast display enables high-throughput antibody discovery:

• Genotype-phenotype linkage: One approach "links the antigen-binding feature of membrane-expressed Ig, which can be linked to Ig DNA sequence information using our plasmid construct" . This allows direct correlation between binding properties and antibody sequences.

• Bulk sorting and sequencing: "Antigen-binding cells carry the plasmid encoding Ig genes through surface Ig so that the selection process in bulk format enriches the relevant plasmids for use in further experiments" .

• Tite-Seq methodology: This approach measures "binding titration curves and corresponding affinities for thousands of protein variants simultaneously" . Cells are sorted into multiple bins based on binding signal intensity at different antigen concentrations, followed by sequencing to determine enrichment patterns.

• Computational analysis: Deep learning models can be trained on sequence data to "accurately distinguish between the human antibodies to SARS-CoV-2 spike protein and those to influenza hemagglutinin protein" . This enables computational prediction of binding properties from sequence data.

• Library recovery: After sorting, plasmids can be recovered from yeast cells through methods like "yeast lysis reaction containing glass beads, Phenol/chloroform/isoamyl alcohol and yeast lysis buffer" for subsequent analysis or additional rounds of selection.

What approaches can be used to accurately measure binding affinities of yeast-displayed antibodies?

Several methodologies enable accurate binding affinity determination directly on yeast surfaces:

• Titration curve analysis: By exposing yeast-displayed antibodies to a range of antigen concentrations (from 0 M to 10⁻⁶ M), complete binding curves can be generated. Research shows that "Reaction volumes were large enough to ensure that >10⁷ antigen molecules per scFv were present, assuming ~10⁵ scFvs per cell" .

• Multi-parameter flow cytometry: This allows simultaneous measurement of antibody display level (via epitope tags) and antigen binding, enabling normalization of binding signal to display level for accurate affinity comparisons .

• Sorted cell populations analysis: The Tite-Seq method involves sorting cells into multiple bins based on binding signal at each antigen concentration, then using the distribution across bins to calculate binding parameters .

• Population profile analysis: Research indicates that "the population profile, defined by the fluorescence intensity during flow cytometry, directly reflected the affinity of a clone" .

• Quantitative data modeling: Mathematical models can be applied to flow cytometry data to extract dissociation constants (KD) and other binding parameters with high accuracy .

These approaches enable precise characterization of binding properties while antibodies remain displayed on the yeast cell surface.

What strategies can improve the functional quality of displayed antibodies?

Several approaches have been shown to enhance the functional quality of yeast-displayed antibodies:

The research emphasizes the importance of considering tradeoffs between quality and quantity of antibody display for individual antibody clones.

How can chemical diversification enhance yeast-displayed antibody libraries?

Recent innovations have expanded the chemical diversity of yeast-displayed antibodies:

• Noncanonical amino acid incorporation: A "yeast display-based platform for the discovery of chemically diversified antibodies" uses "noncanonical amino acid (ncAA) incorporation and subsequent bioorthogonal click chemistry conjugations" .

• Diverse functional groups: A "polyspecific orthogonal translation system enables introduction of chemical groups with various properties, including photo-reactive, proximity-reactive, and click chemistry-enabled functional groups for library screening" .

• Proximity-induced crosslinking: Incorporation of amino acids like "O-(2-bromoethyl)tyrosine (OBeY), a weakly electrophilic ncAA capable of undergoing proximity-induced crosslinking to a target" enables new binding modalities .

• Enhanced binding stability: Research showed "higher retention of binding for OBeY-substituted clones compared to clones substituted with ncAAs lacking electrophilic side chains after denaturation" .

• Billion-member libraries: The technology allows creation of "a billion-member antibody library that supports the presentation of a range of chemistries within antibody variable domains" .

This chemical expansion offers "new opportunities for identifying and characterizing antibodies with properties beyond what is accessible with the canonical amino acids" .

What experimental design strategies can help develop broadly neutralizing antibodies?

Several approaches have proven effective for developing broadly neutralizing antibodies:

• Multi-antigen screening: Using multiple related antigens as probes allows identification of antibodies that recognize conserved epitopes. For example, researchers used "HA proteins as probes: A/Puerto Rico/8/1934 (H1N1), designated as PR8, and A/Okuda/1957 (H2N2), designated as H2" to isolate broadly reactive antibodies.

• Sequential sorting strategy: A stepped approach using increasingly stringent selection criteria can enrich for broadly neutralizing antibodies. For instance, first collecting cells that bind to one antigen, then those that bind to multiple antigens .

• Deep repertoire mining: A "next-generation antigen barcoding approach to deeply survey the SARS-CoV-2-specific antibody response" enabled identification of broadly neutralizing antibodies like "CC24.2, a pan-sarbecovirus neutralizing antibody that targets a unique receptor-binding domain (RBD) epitope" .

• Antibody cocktail development: Research shows that "broadly protective mAb cocktails are in some ways preferable to monotherapy, as increased epitope diversity provides added protection against viral escape" .

• Epitope focusing: Targeting conserved epitopes that are less susceptible to mutation can lead to broader neutralization. For example, antibodies targeting "a novel RBD epitope" exhibited "pan-sarbecovirus breadth that includes the BA, BQ, and XBB variants" .

What are the most common troubleshooting issues in yeast antibody display?

Researchers frequently encounter several challenges when working with yeast antibody display:

• Variable display efficiency: Different antibody clones may display with varying efficiency. Research shows scFv display levels varied from 31-46%, while Fab formats showed more consistent display (41-43%) .

• Improper antibody assembly: This is particularly challenging for Fab display, which requires proper assembly of heavy and light chains. Co-expression of chaperones and use of ER retention sequences can help address this issue .

• Post-translational modification differences: Yeast glycosylation patterns differ from mammalian cells, potentially affecting antibody properties .

• Clone bias during selection: Some clones may be enriched due to display advantage rather than binding affinity. Normalizing binding signal to display level helps address this .

• Quality-quantity tradeoff: Strategies that improve functional quality often reduce display quantity. For example, "fusing ER retention sequences (ERSs) with light chain also enhanced Fab display quality at the expense of display quantity" .

• Loss of genotype-phenotype linkage: If using two yeast hosts, there is "a potential loss of genotype-phenotype linkage," though this approach offers "the major advantage that it is possible to switch between antibody display for screening and antibody secretion for functional characterization" .

Understanding these common issues and their solutions can significantly improve the success rate of yeast antibody display experiments.